Chemical Probes logo
BI-653048 | BI 653048 : Agonist of NR3C1
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (0 reviews)
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
NR3C1
  • IC50:55 nM
  • IC50:23 nM
Agonist
2 µM
1 uM

Selectivity

In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selectivity within target family: > 100 fold selectivity against related nuclear receptors (PGR, NR3 ...

Potency
Cellular
In Vitro

NR3C1

Mode of Action: Agonist

Structure-Activity-Relationship data available? No

DOI Reference: 10.1021/ml500387y

Negative Control Compounds

BI 3047
Notes: BI-3047 (enantiomer): NR3C1: IC50 >2 µM (Fluorescence polarization assay); Clean GPCR scan

Chemical Information

Molecular Formula C23H25F4N3O4S
SMILEs CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1
InChI InChI=1S/C23H25F4N3O4S/c1-4-35(33,34)19-8-13-7-15(30-18(13)11-29-19)10-22(32,23(25,26)27)12-21(2,3)17-6-5-14(24)9-16(17)20(28)31/h5-9,11,30,32H,4,10,12H2,1-3H3,(H2,28,31)/t22-/m0/s1
Molecular weight 515.15 Da
AlogP 0.0
HBond acceptors 7
HBond donors 4
Atoms 60

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews

by SERP
(on 22 Feb 2022 )
Cellular Use Rating
Consider that BI 653048 has a preference for transrepression over transcriptional activation of GR and therefore only activates some mechanisms of GR activity fully (see 10.1021/ml500387y). BI 653048 should...
by SERP+
(on 17 Jun 2024 )
Cellular Use Rating
Target binding and in cellular target engagement are well demonstrated. The users should be aware that compound BI-653048 favors transrepression over transactivation and does not cover all GR-activities...
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria